Pfizer Inc Stock Price on October 7, 2024
| PFE Stock | USD 26.21 0.38 1.47% |
Below is the normalized historical share price chart for Pfizer Inc extending back to November 05, 1984. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Pfizer stands at 26.21, as last reported on the 1st of December, with the highest price reaching 26.23 and the lowest price hitting 25.77 during the day.
If you're considering investing in Pfizer Stock, it is important to understand the factors that can impact its price. Pfizer Inc maintains Sharpe Ratio (i.e., Efficiency) of -0.0609, which implies the firm had a -0.0609% return per unit of risk over the last 3 months. Pfizer Inc exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check Pfizer's Risk Adjusted Performance of (0.05), coefficient of variation of (1,339), and Variance of 2.04 to confirm the risk estimate we provide.
At present, Pfizer's Liabilities And Stockholders Equity is projected to increase significantly based on the last few years of reporting. Sale Purchase Of Stock is expected to grow at the current pace this year, whereas Other Stockholder Equity is projected to grow to (20.8 B). . At present, Pfizer's Price Earnings Ratio is projected to increase significantly based on the last few years of reporting. The current year's Price To Operating Cash Flows Ratio is expected to grow to 22.12, whereas Price Earnings To Growth Ratio is projected to grow to (0.78). Pfizer Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 13th of August 2012 | 200 Day MA 28.0734 | 50 Day MA 27.8996 | Beta 0.615 |
Pfizer |
Sharpe Ratio = -0.0609
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | PFE |
Estimated Market Risk
| 1.41 actual daily | 12 88% of assets are more volatile |
Expected Return
| -0.09 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.06 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Pfizer is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Pfizer by adding Pfizer to a well-diversified portfolio.
Price Book 1.6095 | Enterprise Value Ebitda 14.8306 | Price Sales 2.5016 | Shares Float 5.7 B | Dividend Share 1.67 |
Related Headline
Amicus Therapeutics Headline on 7th of October 2024
Bradley L. Campbell Sells 7,500 Shares of Amicus Therapeutic... by thelincolnianonline.com
Amicus Therapeutics, Inc. CEO Bradley L. Campbell sold 7,500 shares of the companys stock in a transaction that occurred on Tuesday, October 1st. The stock was sold at an average price of 10.60, for a total value of 79,500.00. Following the transaction, the chief executive officer now directly owns 886,654
Pfizer Valuation on October 7, 2024
It is possible to determine the worth of Pfizer on a given historical date. On October 7, 2024 Pfizer was worth 28.92 at the beginning of the trading date compared to the closed value of 28.75. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Pfizer stock. Still, in general, we apply an absolute valuation method to find Pfizer's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Pfizer where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Pfizer's related companies.
| Open | High | Low | Close | Volume | |
| 27.86 | 28.15 | 27.81 | 28.14 | 28,786,881 | |
10/07/2024 | 28.92 | 29.38 | 28.66 | 28.75 | 51,426,594 |
| 28.76 | 29.04 | 28.56 | 28.73 | 29,126,561 |
| Backtest Pfizer | | | Pfizer History | | | Pfizer Valuation | Previous | Next |
Pfizer Trading Date Momentum on October 7, 2024
| On October 08 2024 Pfizer Inc was traded for 28.73 at the closing time. Highest Pfizer's price during the trading hours was 29.04 and the lowest price during the day was 28.56 . The net volume was 29.1 M. The overall trading history on the 8th of October contributed to the next trading period price depreciation. The trading delta at closing time to the next next day price was 0.07% . The trading delta at closing time to current price is 0.97% . |
Pfizer Inc Fundamentals Correlations and Trends
By evaluating Pfizer's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Pfizer's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Pfizer financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Pfizer Stock history
Pfizer investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Pfizer is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Pfizer Inc will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Pfizer stock prices may prove useful in developing a viable investing in Pfizer
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 5.7 B | 5.7 B | |
| Net Income Applicable To Common Shares | 36.1 B | 37.9 B |
Pfizer Stock Technical Analysis
Pfizer technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Pfizer Period Price Range
Low | December 1, 2024
| High |
0.00 | 0.00 |
Pfizer Inc cannot be verified against its exchange. Please verify the symbol is currently traded on New York Stock Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Pfizer December 1, 2024 Market Strength
Market strength indicators help investors to evaluate how Pfizer stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Pfizer shares will generate the highest return on investment. By undertsting and applying Pfizer stock market strength indicators, traders can identify Pfizer Inc entry and exit signals to maximize returns
Pfizer Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Pfizer's price direction in advance. Along with the technical and fundamental analysis of Pfizer Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Pfizer to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.05) | |||
| Jensen Alpha | (0.17) | |||
| Total Risk Alpha | (0.36) | |||
| Treynor Ratio | (0.28) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Complementary Tools for Pfizer Stock analysis
When running Pfizer's price analysis, check to measure Pfizer's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pfizer is operating at the current time. Most of Pfizer's value examination focuses on studying past and present price action to predict the probability of Pfizer's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pfizer's price. Additionally, you may evaluate how the addition of Pfizer to your portfolios can decrease your overall portfolio volatility.
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets |